Published in J Low Genit Tract Dis on October 01, 2017
The Genome sequence of the SARS-associated coronavirus. Science (2003) 16.68
Identification of severe acute respiratory syndrome in Canada. N Engl J Med (2003) 14.29
Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst (2005) 5.65
Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol (2005) 4.31
Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis (2004) 4.29
Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. JAMA (2013) 3.06
Novel avian influenza H7N3 strain outbreak, British Columbia. Emerg Infect Dis (2004) 2.90
Hepatitis C virus reinfection in injection drug users. Hepatology (2006) 2.25
Modeling control strategies of respiratory pathogens. Emerg Infect Dis (2005) 1.79
Problems with the fast-check HIV rapid test kits. CMAJ (2002) 1.64
Burden of disease and cost of chronic hepatitis C infection in Canada. Can J Gastroenterol Hepatol (2014) 1.59
A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. Clin Infect Dis (2012) 1.58
Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users. Can J Gastroenterol (2007) 1.44
Protective measures and human antibody response during an avian influenza H7N3 outbreak in poultry in British Columbia, Canada. CMAJ (2007) 1.43
Population-based outcomes for small cell lung cancer: impact of standard management policies in British Columbia. Lung Cancer (2004) 1.43
Reinfection with hepatitis C virus following sustained virological response in injection drug users. J Gastroenterol Hepatol (2010) 1.26
Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. J Infect Dis (2014) 1.23
The role of the fallopian tube in ovarian cancer. Clin Adv Hematol Oncol (2012) 1.23
Determinants of HIV serconversion in an era of increasing HIV infection among young gay and bisexual men. AIDS (2003) 1.19
Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer. Hum Pathol (2003) 1.16
Waist-to-hip ratio and breast cancer mortality. Am J Epidemiol (2003) 1.15
Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection. J Gastroenterol Hepatol (2012) 1.13
Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada. J Urban Health (2004) 1.10
Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C. Am J Gastroenterol (2009) 1.10
Genetic diversity as a marker for timing infection in HIV-infected patients: evaluation of a 6-month window and comparison with BED. J Infect Dis (2012) 1.08
Feasibility of self-collection of specimens for human papillomavirus testing in hard-to-reach women. CMAJ (2007) 1.08
A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial). BMC Cancer (2010) 1.07
Impact of universal preadolescent vaccination against hepatitis B on antenatal seroprevalence of hepatitis B markers in British Columbia women. CMAJ (2003) 1.06
Coordinated response to SARS, Vancouver, Canada. Emerg Infect Dis (2006) 1.04
Age of recipient and number of doses differentially impact human B and T cell immune memory responses to HPV vaccination. Vaccine (2012) 1.04
Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents. Liver Int (2013) 1.01
Effects of positive resection margin and tumor distance from anus on rectal cancer treatment outcomes. Am J Surg (2002) 1.00
Uptake, benefits of and barriers to safer crack use kit (SCUK) distribution programmes in Victoria, Canada--a qualitative exploration. Int J Drug Policy (2011) 0.99
Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016. Euro Surveill (2016) 0.98
Satisfaction and anxiety for women during investigation of an abnormal screening mammogram. Breast Cancer Res Treat (2002) 0.97
Levels of antibodies against cytomegalovirus and Chlamydophila pneumoniae are increased in early onset pre-eclampsia. BJOG (2003) 0.97
The Second Canadian Symposium on hepatitis C virus: a call to action. Can J Gastroenterol (2013) 0.96
Process monitoring of an HIV treatment as prevention program in British Columbia, Canada. J Acquir Immune Defic Syndr (2014) 0.96
Using centralized laboratory data to monitor trends in herpes simplex virus type 1 and 2 infection in British Columbia and the changing etiology of genital herpes. Can J Public Health (2011) 0.96
HCV co-infection in HIV positive population in British Columbia, Canada. BMC Public Health (2010) 0.95
An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus. Can J Infect Dis Med Microbiol (2006) 0.95
An association between cytomegalovirus infection and pre-eclampsia: a case-control study and data synthesis. Acta Obstet Gynecol Scand (2010) 0.94
Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, Canada. Int J Cancer (2014) 0.94
Mortality among British Columbians testing for hepatitis C antibody. BMC Public Health (2013) 0.94
Parvovirus B19 in an immunocompetent adult patient with acute liver failure: an underdiagnosed cause of acute non-A-E viral hepatitis. Can J Gastroenterol (2005) 0.93
Capacity enhancement of hepatitis C virus treatment through integrated, community-based care. Can J Gastroenterol (2008) 0.92
Outcomes of peginterferon alpha-2a and ribavirin hepatitis C therapy in Aboriginal Canadians. Can J Gastroenterol (2008) 0.91
The hotel study: multimorbidity in a community sample living in marginal housing. Am J Psychiatry (2013) 0.90
Mutations acquired during cell culture isolation may affect antigenic characterisation of influenza A(H3N2) clade 3C.2a viruses. Euro Surveill (2016) 0.88
Self-collected versus clinician-collected sampling for sexually transmitted infections: a systematic review and meta-analysis protocol. Syst Rev (2013) 0.88
Targeting screening and social marketing to increase detection of acute HIV infection in men who have sex with men in Vancouver, British Columbia. AIDS (2013) 0.87
Detection of influenza H7N9 virus: all molecular tests are not equal. J Clin Microbiol (2013) 0.86
Personalized risk assessment of drug-related harm is associated with health outcomes. PLoS One (2013) 0.85
Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers. BMC Cancer (2013) 0.84
Methadone use in relation to hepatitis C virus testing in British Columbia. Can J Public Health (2011) 0.84
Does cirrhosis affect quality of life in hepatitis C virus-infected patients? Liver Int (2009) 0.84
Hepatitis C virus and risk of non-Hodgkin lymphoma in British Columbia, Canada. Int J Cancer (2008) 0.83
SARS: a quality management test of our public health safety net. Qual Manag Health Care (2004) 0.83
Towards targeted screening for acute HIV infections in British Columbia. J Int AIDS Soc (2011) 0.83
Serial vaccination and the antigenic distance hypothesis: effects on influenza vaccine effectiveness during A(H3N2) epidemics in Canada, 2010-11 to 2014-15. J Infect Dis (2017) 0.82
Simplifying the implant treatment for an unrestorable premolar with a one-piece implant: a clinical report. J Prosthet Dent (2008) 0.82
The 3rd Canadian Symposium on Hepatitis C Virus: expanding care in the interferon-free era. Can J Gastroenterol Hepatol (2014) 0.82
Women's intentions to receive cervical cancer screening with primary human papillomavirus testing. Int J Cancer (2013) 0.82
Assessing the breast cancer risk distribution for women undergoing screening in British Columbia. Cancer Prev Res (Phila) (2013) 0.81
Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule. Hum Vaccin Immunother (2014) 0.81
Detection of Early Sero-Conversion HIV Infection Using the INSTI HIV-1 Antibody Point-of-Care Test. Open AIDS J (2010) 0.81
Imported fatal hantavirus pulmonary syndrome. Emerg Infect Dis (2007) 0.81
Neurocognitive profiles of marginally housed persons with comorbid substance dependence, viral infection, and psychiatric illness. J Clin Exp Neuropsychol (2014) 0.80
Systematic community- and hospital-based surveillance for enterovirus-D68 in three Canadian provinces, August to December 2014. Euro Surveill (2015) 0.79
Sexually transmitted infection trends among gay or bisexual men from a clinic-based sentinel surveillance system in British Columbia, Canada. Sex Transm Dis (2015) 0.79
Prevalence and incidence of hepatitis C virus in hemodialysis patients in British Columbia: Follow-up after a possible breach in hemodialysis machines. Can J Infect Dis Med Microbiol (2009) 0.79
Acute nosocomial HCV infection detected by NAT of a regular blood donor. Transfusion (2002) 0.78
Avian Influenza A(H7N9) Virus Infection in 2 Travelers Returning from China to Canada, January 2015(1). Emerg Infect Dis (2016) 0.78
Women's intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program. BMC Public Health (2014) 0.78
Publicly funded pegylated interferon-alpha treatment in British Columbia: disparities in treatment patterns for people with hepatitis C. Can J Gastroenterol (2008) 0.78
Patient time costs and out-of-pocket costs in hepatitis C. Liver Int (2012) 0.78
Variability of hepatitis B testing in British Columbian ESRD patients: the case to focus on implementation of guidelines. Am J Kidney Dis (2008) 0.78
Hepatitis C infection among pregnant women in British Columbia: reported prevalence and critical appraisal of current prenatal screening methods. Can J Public Health (2011) 0.77
Longitudinal analysis of genotype distribution of influenza A virus from 2003 to 2005. J Clin Microbiol (2006) 0.77
Mumps virus detection during an outbreak in a highly unvaccinated population in British Columbia. Can J Public Health (2011) 0.77
Hepatitis C, illicit drug use and public health: does Canada really have a viable plan? Can J Public Health (2007) 0.77
Monitoring of hepatitis C virus quasispecies in chronic infection by matrix-assisted laser desorption ionization-time of flight mass spectrometry mutation detection. J Clin Microbiol (2007) 0.77
Detection of influenza A(H3N2) clade 3C.2a viruses in patients with suspected mumps in British Columbia, Canada, during the 2014/15 influenza season. Euro Surveill (2015) 0.77
Successful HCV genotyping of previously failed and low viral load specimens using an HCV RNA qualitative assay based on transcription-mediated amplification in conjunction with the line probe assay. J Clin Virol (2003) 0.76
Local and regional therapy for women with breast cancer in British Columbia. Breast J (2003) 0.76
Prevalence and risk factors for neutralizing antibodies to human papillomavirus types 16 and 18 in HIV-positive men who have sex with men. J Acquir Immune Defic Syndr (2013) 0.75
Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study. Can J Gastroenterol Hepatol (2014) 0.75
West Nile virus finally debuts in British Columbia 10 years after its introduction to North America. Vector Borne Zoonotic Dis (2010) 0.75
Case series of rash associated with influenza B in school children. Influenza Other Respir Viruses (2014) 0.75